Report Categories
View AllRecent Articles
View All
What Simulations Plus SLP disclosed about cost pressures Simulations Plus posts 103 pct EPS beat on solid pharma software demand
NG Novagold Resources beats Q1 earnings estimates by 25 yet shares drop 565 on zero revenue development concerns
MEG Montrose shares gain 518 percent despite steep Q4 2025 earnings miss versus consensus analyst estimates
What tail risk New NMFCZ Neutral 20260427
Memory Chip Supply Constraints Propel DRAM ETF to Record Asset Growth
Solstice Achieves 400M TVL Milestone as NYSEListed Bullish Joins Institutional Allocator Network
Bank Closures on Memorial Day A Guide to the 12 Federal Holidays
South Koreas Deputy PM Warns AIDriven Wealth Must Benefit Public Amid Samsung Labor Unrest
Nvidia Stock Approaches Critical Technical Level Amid Market Uncertainty
Cable One Q1 2026 Earnings EPS Surpasses Estimates Shares Rise 576
VLYPO Q1 2026 Earnings EPS Beat Drives Positive Sentiment for Valley National Bancorp
ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline
PLG Q4 2023 Earnings NarrowerThanExpected Loss Amid Exploration Progress
EFX Q1 2026 Earnings Earnings Beat Estimates Amid Strong Performance
SREA Preferred Notes Rise as Yield Appeal Holds Steady
Hingham Institution for Savings HIFS Holds Steady After Modest Gain Support and Resistance Levels in Focus
Bumble Inc BMBL Shows Resilience Bounces From Key Support Zone
NewHold Investment Corp III Warrants NHICW Surge Over 150 A HighVolatility Move
Circle Internet Group CRCL Surges 55 as Bullish Momentum Builds
ServiceNow NOW Surges 14 Strong Momentum Propels Stock Past Key Levels
US Employment and Unemployment Rate Projections for 2031 Insights from Statista
SY Q1 2026 Earnings EPS Surges Past Estimates with 9115 Surprise
AnheuserBusch InBev Shares Slide After Quarterly Sales Miss Estimates
External Links
European Manufacturers Maintain China Production Despite EU DeRisking Rhetoric
FCNCN Q1 2026 Earnings Strong EPS Beat Driven by Higher Net Interest Income
Spyre Therapeutics SYRE Holds Steady Near Support Amid Low Volatility
GLP1 Weight Loss Drugs Driving Up Prescription Costs CoPays Expected to Rise
Cornwalls Nansledan Development A Retail Blueprint or a Threat to Newquays High Street
The 530 Orange Juice A Case Study in Rising Supermarket Prices
SpaceX Faces Crucial Launch Test as IPO Speculation Intensifies
Nvidia Earnings Report and Commentary Potential Impact of China Chip Restrictions and Trade Policy After Xi Summit
Healthcare and Tech Lead as Broad Market Edges Higher
Adani Power Surpasses Infosys in Market Cap Amid Energy Demand Shift